The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

GARRELL M

Loffler's syndrome. Report of a case associated with the administration of aurothioglucose (Solganal).

Archives of internal medicine. 1960;106:874-7

Podell TE, Klinenberg JR, Kramer LS, Brown HV

Pulmonary toxicity with gold therapy.

Arthritis and rheumatism. 1980;23(3):347-50

Breton JL, Garnier G, Toulouse J, Depierre A

Bronchoalveolar lavage and gold salt-induced pneumonitis.

Chest. 1985;87(3):410

Limpisvasti P, Jones P

Report of a case: gold-associated pulmonary injury.

Hawaii medical journal. 1979;38(2):43-5